Vanguard Group
COYA icon

Vanguard Group’s Coya Therapeutics COYA Stock Holding History

Vanguard Group’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.22M Buy
899,140
+62,747
+8% +$381K ﹤0.01% 3240
2025
Q3 		$4.77M Sell
836,393
-4,078
-0.5% -$24.8K ﹤0.01% 3297
2025
Q2 		$4.83M Hold
840,471
– – ﹤0.01% 3230
2025
Q1 		$5.44M Hold
840,471
– – ﹤0.01% 3137
2024
Q4 		$4.82M Sell
840,471
-4,953
-0.6% -$33.7K ﹤0.01% 3289
2024
Q3 		$5.45M Hold
845,424
– – ﹤0.01% 3241
2024
Q2 		$5.12M Sell
845,424
-2,066
-0.2% -$16.6K ﹤0.01% 3253
2024
Q1 		$8.41M Buy
847,490
+750,338
+772% +$5.88M ﹤0.01% 3055
2023
Q4 		$720K Buy
97,152
+82,948
+584% +$460K ﹤0.01% 3922
2023
Q3 		$54.5K Buy
+14,204
New +$56.5K ﹤0.01% 4401

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Vanguard Group's COYA Position: Q4 2025 in Review

Vanguard Group increased its Coya Therapeutics (COYA) stake by 7.5% in Q4 2025, buying an estimated $381K and bringing the position to 899,140 shares worth $5.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3240.

Vanguard Group first reported a position in COYA in Q3 2023 and has held it in 10 quarters since. The position peaked at $8.41M in Q1 2024. 58 funds tracked by Wall St. Rank hold COYA as of Q4 2025.

  • Vanguard Group held 899,140 shares of Coya Therapeutics worth $5.22M as of Q4 2025.
  • Vanguard Group bought 62,747 Coya Therapeutics shares in Q4 2025, an estimated $381K.
  • Coya Therapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3240 holding.
  • Vanguard Group first reported a position in Coya Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • Vanguard Group's Coya Therapeutics position peaked at $8.41M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Coya Therapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.